Global and United States Antidiabetic Biguanides Market Insights, Forecast to 2027

Global and United States Antidiabetic Biguanides Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Antidiabetic Biguanides Product Introduction
1.2 Market by Type
1.2.1 Global Antidiabetic Biguanides Market Size Growth Rate by Type
1.2.2 Metformin IR
1.2.3 Metformin SR
1.3 Market by Application
1.3.1 Global Antidiabetic Biguanides Market Size Growth Rate by Application
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antidiabetic Biguanides Market Size, Estimates and Forecasts
2.1.1 Global Antidiabetic Biguanides Revenue 2016-2027
2.1.2 Global Antidiabetic Biguanides Sales 2016-2027
2.2 Global Antidiabetic Biguanides, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Antidiabetic Biguanides Historical Market Size by Region (2016-2021)
2.3.1 Global Antidiabetic Biguanides Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Antidiabetic Biguanides Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Antidiabetic Biguanides Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Antidiabetic Biguanides Sales Forecast by Region (2022-2027)
2.4.2 Global Antidiabetic Biguanides Revenue Forecast by Region (2022-2027)
3 Global Antidiabetic Biguanides Competitor Landscape by Players
3.1 Global Top Antidiabetic Biguanides Manufacturers by Sales
3.1.1 Global Antidiabetic Biguanides Sales by Manufacturer (2016-2021)
3.1.2 Global Antidiabetic Biguanides Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Antidiabetic Biguanides Manufacturers by Revenue
3.2.1 Key Antidiabetic Biguanides Manufacturers Covered: Ranking by Revenue
3.2.2 Global Antidiabetic Biguanides Revenue by Manufacturers (2016-2021)
3.2.3 Global Antidiabetic Biguanides Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Antidiabetic Biguanides Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Antidiabetic Biguanides Revenue in 2020
3.2.6 Global Antidiabetic Biguanides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Antidiabetic Biguanides Price by Manufacturers
3.4 Global Antidiabetic Biguanides Manufacturing Base Distribution, Product Types
3.4.1 Antidiabetic Biguanides Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antidiabetic Biguanides Product Type
3.4.3 Date of International Manufacturers Enter into Antidiabetic Biguanides Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Antidiabetic Biguanides Market Size by Type (2016-2021)
4.1.1 Global Antidiabetic Biguanides Sales by Type (2016-2021)
4.1.2 Global Antidiabetic Biguanides Revenue by Type (2016-2021)
4.1.3 Antidiabetic Biguanides Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Antidiabetic Biguanides Market Size Forecast by Type (2022-2027)
4.2.1 Global Antidiabetic Biguanides Sales Forecast by Type (2022-2027)
4.2.2 Global Antidiabetic Biguanides Revenue Forecast by Type (2022-2027)
4.2.3 Antidiabetic Biguanides Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Antidiabetic Biguanides Market Size by Application (2016-2021)
5.1.1 Global Antidiabetic Biguanides Sales by Application (2016-2021)
5.1.2 Global Antidiabetic Biguanides Revenue by Application (2016-2021)
5.1.3 Antidiabetic Biguanides Price by Application (2016-2021)
5.2 Antidiabetic Biguanides Market Size Forecast by Application (2022-2027)
5.2.1 Global Antidiabetic Biguanides Sales Forecast by Application (2022-2027)
5.2.2 Global Antidiabetic Biguanides Revenue Forecast by Application (2022-2027)
5.2.3 Global Antidiabetic Biguanides Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Antidiabetic Biguanides Market Size YoY Growth 2016-2027
6.1.1 United States Antidiabetic Biguanides Sales YoY Growth 2016-2027
6.1.2 United States Antidiabetic Biguanides Revenue YoY Growth 2016-2027
6.1.3 United States Antidiabetic Biguanides Market Share in Global Market 2016-2027
6.2 United States Antidiabetic Biguanides Market Size by Players (International and Local Players)
6.2.1 United States Top Antidiabetic Biguanides Players by Sales (2016-2021)
6.2.2 United States Top Antidiabetic Biguanides Players by Revenue (2016-2021)
6.3 United States Antidiabetic Biguanides Historic Market Review by Type (2016-2021)
6.3.1 United States Antidiabetic Biguanides Sales Market Share by Type (2016-2021)
6.3.2 United States Antidiabetic Biguanides Revenue Market Share by Type (2016-2021)
6.3.3 United States Antidiabetic Biguanides Price by Type (2016-2021)
6.4 United States Antidiabetic Biguanides Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Antidiabetic Biguanides Sales Forecast by Type (2022-2027)
6.4.2 United States Antidiabetic Biguanides Revenue Forecast by Type (2022-2027)
6.4.3 United States Antidiabetic Biguanides Price Forecast by Type (2022-2027)
6.5 United States Antidiabetic Biguanides Historic Market Review by Application (2016-2021)
6.5.1 United States Antidiabetic Biguanides Sales Market Share by Application (2016-2021)
6.5.2 United States Antidiabetic Biguanides Revenue Market Share by Application (2016-2021)
6.5.3 United States Antidiabetic Biguanides Price by Application (2016-2021)
6.6 United States Antidiabetic Biguanides Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Antidiabetic Biguanides Sales Forecast by Application (2022-2027)
6.6.2 United States Antidiabetic Biguanides Revenue Forecast by Application (2022-2027)
6.6.3 United States Antidiabetic Biguanides Price Forecast by Application (2022-2027)
7 North America
7.1 North America Antidiabetic Biguanides Market Size YoY Growth 2016-2027
7.2 North America Antidiabetic Biguanides Market Facts & Figures by Country
7.2.1 North America Antidiabetic Biguanides Sales by Country (2016-2021)
7.2.2 North America Antidiabetic Biguanides Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Antidiabetic Biguanides Market Size YoY Growth 2016-2027
8.2 Asia Pacific Antidiabetic Biguanides Market Facts & Figures by Region
8.2.1 Asia Pacific Antidiabetic Biguanides Sales by Region (2016-2021)
8.2.2 Asia Pacific Antidiabetic Biguanides Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Antidiabetic Biguanides Market Size YoY Growth 2016-2027
9.2 Europe Antidiabetic Biguanides Market Facts & Figures by Country
9.2.1 Europe Antidiabetic Biguanides Sales by Country (2016-2021)
9.2.2 Europe Antidiabetic Biguanides Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Antidiabetic Biguanides Market Size YoY Growth 2016-2027
10.2 Latin America Antidiabetic Biguanides Market Facts & Figures by Country
10.2.1 Latin America Antidiabetic Biguanides Sales by Country (2016-2021)
10.2.2 Latin America Antidiabetic Biguanides Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Antidiabetic Biguanides Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Antidiabetic Biguanides Market Facts & Figures by Country
11.2.1 Middle East and Africa Antidiabetic Biguanides Sales by Country (2016-2021)
11.2.2 Middle East and Africa Antidiabetic Biguanides Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer Antidiabetic Biguanides Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Antidiabetic Biguanides Products Offered
12.1.5 Pfizer Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Corporation Information
12.2.2 AstraZeneca Description and Business Overview
12.2.3 AstraZeneca Antidiabetic Biguanides Sales, Revenue and Gross Margin (2016-2021)
12.2.4 AstraZeneca Antidiabetic Biguanides Products Offered
12.2.5 AstraZeneca Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Corporation Information
12.3.2 GlaxoSmithKline Description and Business Overview
12.3.3 GlaxoSmithKline Antidiabetic Biguanides Sales, Revenue and Gross Margin (2016-2021)
12.3.4 GlaxoSmithKline Antidiabetic Biguanides Products Offered
12.3.5 GlaxoSmithKline Recent Development
12.4 Merck & Co
12.4.1 Merck & Co Corporation Information
12.4.2 Merck & Co Description and Business Overview
12.4.3 Merck & Co Antidiabetic Biguanides Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Merck & Co Antidiabetic Biguanides Products Offered
12.4.5 Merck & Co Recent Development
12.5 Eli Lilly
12.5.1 Eli Lilly Corporation Information
12.5.2 Eli Lilly Description and Business Overview
12.5.3 Eli Lilly Antidiabetic Biguanides Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Eli Lilly Antidiabetic Biguanides Products Offered
12.5.5 Eli Lilly Recent Development
12.6 Sanofi
12.6.1 Sanofi Corporation Information
12.6.2 Sanofi Description and Business Overview
12.6.3 Sanofi Antidiabetic Biguanides Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Sanofi Antidiabetic Biguanides Products Offered
12.6.5 Sanofi Recent Development
12.7 Takeda Pharmaceuticals
12.7.1 Takeda Pharmaceuticals Corporation Information
12.7.2 Takeda Pharmaceuticals Description and Business Overview
12.7.3 Takeda Pharmaceuticals Antidiabetic Biguanides Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Takeda Pharmaceuticals Antidiabetic Biguanides Products Offered
12.7.5 Takeda Pharmaceuticals Recent Development
12.8 Novo Nordisk
12.8.1 Novo Nordisk Corporation Information
12.8.2 Novo Nordisk Description and Business Overview
12.8.3 Novo Nordisk Antidiabetic Biguanides Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Novo Nordisk Antidiabetic Biguanides Products Offered
12.8.5 Novo Nordisk Recent Development
12.9 Servier Laboratories
12.9.1 Servier Laboratories Corporation Information
12.9.2 Servier Laboratories Description and Business Overview
12.9.3 Servier Laboratories Antidiabetic Biguanides Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Servier Laboratories Antidiabetic Biguanides Products Offered
12.9.5 Servier Laboratories Recent Development
12.10 Boehringer Ingelheim
12.10.1 Boehringer Ingelheim Corporation Information
12.10.2 Boehringer Ingelheim Description and Business Overview
12.10.3 Boehringer Ingelheim Antidiabetic Biguanides Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Boehringer Ingelheim Antidiabetic Biguanides Products Offered
12.10.5 Boehringer Ingelheim Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer Antidiabetic Biguanides Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Pfizer Antidiabetic Biguanides Products Offered
12.11.5 Pfizer Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Antidiabetic Biguanides Industry Trends
13.2 Antidiabetic Biguanides Market Drivers
13.3 Antidiabetic Biguanides Market Challenges
13.4 Antidiabetic Biguanides Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antidiabetic Biguanides Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Antidiabetic Biguanides Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Metformin IR
Table 3. Major Manufacturers of Metformin SR
Table 4. Global Antidiabetic Biguanides Market Size Growth Rate by Application (2021-2027) & (K Pcs)
Table 5. Global Antidiabetic Biguanides Market Size by Region (K Pcs) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Antidiabetic Biguanides Sales by Regions (2016-2021) & (K Pcs)
Table 7. Global Antidiabetic Biguanides Sales Market Share by Regions (2016-2021)
Table 8. Global Antidiabetic Biguanides Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Antidiabetic Biguanides Sales Forecast by Region (2022-2027) & (K Pcs)
Table 10. Global Antidiabetic Biguanides Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Antidiabetic Biguanides Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Antidiabetic Biguanides Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Antidiabetic Biguanides Sales by Manufacturers (2016-2021) (K Pcs)
Table 14. Global Antidiabetic Biguanides Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Antidiabetic Biguanides Manufacturers by Revenue (US$ Million) in 2020
Table 16. Antidiabetic Biguanides Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Antidiabetic Biguanides Revenue Share by Manufacturers (2016-2021)
Table 18. Global Antidiabetic Biguanides Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Antidiabetic Biguanides by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antidiabetic Biguanides as of 2020)
Table 20. Key Manufacturers Antidiabetic Biguanides Price (2016-2021) (USD/Pcs)
Table 21. Antidiabetic Biguanides Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Antidiabetic Biguanides Product Type
Table 23. Date of International Manufacturers Enter into Antidiabetic Biguanides Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Antidiabetic Biguanides Sales by Type (2016-2021) (K Pcs)
Table 26. Global Antidiabetic Biguanides Sales Share by Type (2016-2021)
Table 27. Global Antidiabetic Biguanides Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Antidiabetic Biguanides Revenue Share by Type (2016-2021)
Table 29. Antidiabetic Biguanides Average Selling Price (ASP) by Type (2016-2021) & (USD/Pcs)
Table 30. Global Antidiabetic Biguanides Sales Forecast by Type (2022-2027) & (K Pcs)
Table 31. Global Antidiabetic Biguanides Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Antidiabetic Biguanides Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Antidiabetic Biguanides Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Antidiabetic Biguanides Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Pcs)
Table 35. Global Antidiabetic Biguanides Sales by Application (2016-2021) (K Pcs)
Table 36. Global Antidiabetic Biguanides Sales Share by Application (2016-2021)
Table 37. Global Antidiabetic Biguanides Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Antidiabetic Biguanides Revenue Share by Application (2016-2021)
Table 39. Antidiabetic Biguanides Average Selling Price (ASP) by Application (2016-2021) & (USD/Pcs)
Table 40. Global Antidiabetic Biguanides Sales Forecast by Application (2022-2027) & (K Pcs)
Table 41. Global Antidiabetic Biguanides Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Antidiabetic Biguanides Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Antidiabetic Biguanides Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Antidiabetic Biguanides Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Pcs)
Table 45. United States Antidiabetic Biguanides Sales (K Pcs) of Key Companies (2016-2021)
Table 46. United States Antidiabetic Biguanides Sales Share by Company (2016-2021)
Table 47. United States Antidiabetic Biguanides Revenue (US$ Million) by Company (2016-2021)
Table 48. United States Antidiabetic Biguanides Revenue Share by Company (2016-2021)
Table 49. United States Antidiabetic Biguanides Sales (K Pcs) by Type (2016-2021)
Table 50. United States Antidiabetic Biguanides Sales Share by Type (2016-2021)
Table 51. United States Antidiabetic Biguanides Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. United States Antidiabetic Biguanides Price (USD/Pcs) by Type (2016-2021)
Table 53. United States Antidiabetic Biguanides Sales (K Pcs) by Type (2022-2027)
Table 54. United States Antidiabetic Biguanides Sales Share by Type (2022-2027)
Table 55. United States Antidiabetic Biguanides Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. United States Antidiabetic Biguanides Revenue Share by Type (2022-2027)
Table 57. United States Antidiabetic Biguanides Price (USD/Pcs) by Type (2022-2027)
Table 58. United States Antidiabetic Biguanides Sales (K Pcs) by Application (2016-2021)
Table 59. United States Antidiabetic Biguanides Sales Share by Application (2016-2021)
Table 60. United States Antidiabetic Biguanides Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. United States Antidiabetic Biguanides Price (USD/Pcs) by Application (2016-2021)
Table 62. United States Antidiabetic Biguanides Sales (K Pcs) by Application (2022-2027)
Table 63. United States Antidiabetic Biguanides Sales Share by Application (2022-2027)
Table 64. United States Antidiabetic Biguanides Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. United States Antidiabetic Biguanides Revenue Share by Application (2022-2027)
Table 66. United States Antidiabetic Biguanides Price (USD/Pcs) by Application (2022-2027)
Table 67. North America Antidiabetic Biguanides Sales by Country (2016-2021) & (K Pcs)
Table 68. North America Antidiabetic Biguanides Sales Market Share by Country (2016-2021)
Table 69. North America Antidiabetic Biguanides Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Antidiabetic Biguanides Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Antidiabetic Biguanides Sales by Region (2016-2021) & (K Pcs)
Table 72. Asia Pacific Antidiabetic Biguanides Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Antidiabetic Biguanides Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Antidiabetic Biguanides Revenue Market Share by Region (2016-2021)
Table 75. Europe Antidiabetic Biguanides Sales by Country (2016-2021) & (K Pcs)
Table 76. Europe Antidiabetic Biguanides Sales Market Share by Country (2016-2021)
Table 77. Europe Antidiabetic Biguanides Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Antidiabetic Biguanides Revenue Market Share by Country (2016-2021)
Table 79. Latin America Antidiabetic Biguanides Sales by Country (2016-2021) & (K Pcs)
Table 80. Latin America Antidiabetic Biguanides Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Antidiabetic Biguanides Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Antidiabetic Biguanides Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Antidiabetic Biguanides Sales by Country (2016-2021) & (K Pcs)
Table 84. Middle East and Africa Antidiabetic Biguanides Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Antidiabetic Biguanides Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Antidiabetic Biguanides Revenue Market Share by Country (2016-2021)
Table 87. Pfizer Corporation Information
Table 88. Pfizer Description and Business Overview
Table 89. Pfizer Antidiabetic Biguanides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 90. Pfizer Antidiabetic Biguanides Product
Table 91. Pfizer Recent Development
Table 92. AstraZeneca Corporation Information
Table 93. AstraZeneca Description and Business Overview
Table 94. AstraZeneca Antidiabetic Biguanides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 95. AstraZeneca Product
Table 96. AstraZeneca Recent Development
Table 97. GlaxoSmithKline Corporation Information
Table 98. GlaxoSmithKline Description and Business Overview
Table 99. GlaxoSmithKline Antidiabetic Biguanides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 100. GlaxoSmithKline Product
Table 101. GlaxoSmithKline Recent Development
Table 102. Merck & Co Corporation Information
Table 103. Merck & Co Description and Business Overview
Table 104. Merck & Co Antidiabetic Biguanides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 105. Merck & Co Product
Table 106. Merck & Co Recent Development
Table 107. Eli Lilly Corporation Information
Table 108. Eli Lilly Description and Business Overview
Table 109. Eli Lilly Antidiabetic Biguanides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 110. Eli Lilly Product
Table 111. Eli Lilly Recent Development
Table 112. Sanofi Corporation Information
Table 113. Sanofi Description and Business Overview
Table 114. Sanofi Antidiabetic Biguanides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 115. Sanofi Product
Table 116. Sanofi Recent Development
Table 117. Takeda Pharmaceuticals Corporation Information
Table 118. Takeda Pharmaceuticals Description and Business Overview
Table 119. Takeda Pharmaceuticals Antidiabetic Biguanides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 120. Takeda Pharmaceuticals Product
Table 121. Takeda Pharmaceuticals Recent Development
Table 122. Novo Nordisk Corporation Information
Table 123. Novo Nordisk Description and Business Overview
Table 124. Novo Nordisk Antidiabetic Biguanides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 125. Novo Nordisk Product
Table 126. Novo Nordisk Recent Development
Table 127. Servier Laboratories Corporation Information
Table 128. Servier Laboratories Description and Business Overview
Table 129. Servier Laboratories Antidiabetic Biguanides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 130. Servier Laboratories Product
Table 131. Servier Laboratories Recent Development
Table 132. Boehringer Ingelheim Corporation Information
Table 133. Boehringer Ingelheim Description and Business Overview
Table 134. Boehringer Ingelheim Antidiabetic Biguanides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 135. Boehringer Ingelheim Product
Table 136. Boehringer Ingelheim Recent Development
Table 137. Bristol-Myers Squibb Corporation Information
Table 138. Bristol-Myers Squibb Description and Business Overview
Table 139. Bristol-Myers Squibb Antidiabetic Biguanides Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 140. Bristol-Myers Squibb Product
Table 141. Bristol-Myers Squibb Recent Development
Table 142. Antidiabetic Biguanides Market Trends
Table 143. Antidiabetic Biguanides Market Drivers
Table 144. Antidiabetic Biguanides Market Challenges
Table 145. Antidiabetic Biguanides Market Restraints
Table 146. Antidiabetic Biguanides Customers List
Table 147. Antidiabetic Biguanides Distributors List
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Antidiabetic Biguanides Product Picture
Figure 2. Global Antidiabetic Biguanides Sales Market Share by Type in 2020 & 2027
Figure 3. Metformin IR Product Picture
Figure 4. Metformin SR Product Picture
Figure 5. Global Antidiabetic Biguanides Sales Market Share by Application in 2020 & 2027
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Other
Figure 9. Antidiabetic Biguanides Report Years Considered
Figure 10. Global Antidiabetic Biguanides Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Antidiabetic Biguanides Market Size 2016-2027 (US$ Million)
Figure 12. Global Antidiabetic Biguanides Sales 2016-2027 (K Pcs)
Figure 13. Global Antidiabetic Biguanides Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Antidiabetic Biguanides Sales Market Share by Region (2016-2021)
Figure 15. Global Antidiabetic Biguanides Sales Market Share by Region in 2020
Figure 16. Global Antidiabetic Biguanides Revenue Market Share by Region (2016-2021)
Figure 17. Global Antidiabetic Biguanides Revenue Market Share by Region in 2020
Figure 18. Global Antidiabetic Biguanides Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Antidiabetic Biguanides Revenue in 2020
Figure 20. Antidiabetic Biguanides Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Antidiabetic Biguanides Sales Market Share by Type (2016-2021)
Figure 22. Global Antidiabetic Biguanides Sales Market Share by Type in 2020
Figure 23. Global Antidiabetic Biguanides Revenue Market Share by Type (2016-2021)
Figure 24. Global Antidiabetic Biguanides Revenue Market Share by Type in 2020
Figure 25. Global Antidiabetic Biguanides Sales Market Share by Application (2016-2021)
Figure 26. Global Antidiabetic Biguanides Sales Market Share by Application in 2020
Figure 27. Global Antidiabetic Biguanides Revenue Market Share by Application (2016-2021)
Figure 28. Global Antidiabetic Biguanides Revenue Market Share by Application in 2020
Figure 29. United States Antidiabetic Biguanides Sales Growth Rate 2016-2027 (K Pcs)
Figure 30. United States Antidiabetic Biguanides Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. United States Antidiabetic Biguanides Market Share in Global Market 2016-2027
Figure 32. United States 5 and 10 Largest Antidiabetic Biguanides Players Market Share by Revenue in Antidiabetic Biguanides in 2020
Figure 33. United States Antidiabetic Biguanides Revenue Share by Type (2016-2021)
Figure 34. United States Antidiabetic Biguanides Revenue Growth Rate by Type in 2016 & 2020
Figure 35. United States Antidiabetic Biguanides Revenue Share by Application (2016-2021)
Figure 36. United States Antidiabetic Biguanides Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Antidiabetic Biguanides Sales Growth Rate 2016-2021 (K Pcs)
Figure 38. North America Antidiabetic Biguanides Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Antidiabetic Biguanides Sales Market Share by Country in 2020
Figure 40. North America Antidiabetic Biguanides Revenue Market Share by Country in 2020
Figure 41. U.S. Antidiabetic Biguanides Sales Growth Rate (2016-2021) (K Pcs)
Figure 42. U.S. Antidiabetic Biguanides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Antidiabetic Biguanides Sales Growth Rate (2016-2021) (K Pcs)
Figure 44. Canada Antidiabetic Biguanides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Antidiabetic Biguanides Sales Growth Rate 2016-2021 (K Pcs)
Figure 46. Europe Antidiabetic Biguanides Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Antidiabetic Biguanides Sales Market Share by Country in 2020
Figure 48. Europe Antidiabetic Biguanides Revenue Market Share by Country in 2020
Figure 49. Germany Antidiabetic Biguanides Sales Growth Rate (2016-2021) (K Pcs)
Figure 50. Germany Antidiabetic Biguanides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Antidiabetic Biguanides Sales Growth Rate (2016-2021) (K Pcs)
Figure 52. France Antidiabetic Biguanides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Antidiabetic Biguanides Sales Growth Rate (2016-2021) (K Pcs)
Figure 54. U.K. Antidiabetic Biguanides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Antidiabetic Biguanides Sales Growth Rate (2016-2021) (K Pcs)
Figure 56. Italy Antidiabetic Biguanides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Antidiabetic Biguanides Sales Growth Rate (2016-2021) (K Pcs)
Figure 58. Russia Antidiabetic Biguanides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Antidiabetic Biguanides Sales Growth Rate 2016-2021 (K Pcs)
Figure 60. Asia Pacific Antidiabetic Biguanides Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Antidiabetic Biguanides Sales Market Share by Region in 2020
Figure 62. Asia Pacific Antidiabetic Biguanides Revenue Market Share by Region in 2020
Figure 63. China Antidiabetic Biguanides Sales Growth Rate (2016-2021) (K Pcs)
Figure 64. China Antidiabetic Biguanides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Antidiabetic Biguanides Sales Growth Rate (2016-2021) (K Pcs)
Figure 66. Japan Antidiabetic Biguanides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Antidiabetic Biguanides Sales Growth Rate (2016-2021) (K Pcs)
Figure 68. South Korea Antidiabetic Biguanides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Antidiabetic Biguanides Sales Growth Rate (2016-2021) (K Pcs)
Figure 70. India Antidiabetic Biguanides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Antidiabetic Biguanides Sales Growth Rate (2016-2021) (K Pcs)
Figure 72. Australia Antidiabetic Biguanides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. China Taiwan Antidiabetic Biguanides Sales Growth Rate (2016-2021) (K Pcs)
Figure 74. China Taiwan Antidiabetic Biguanides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Antidiabetic Biguanides Sales Growth Rate (2016-2021) (K Pcs)
Figure 76. Indonesia Antidiabetic Biguanides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Antidiabetic Biguanides Sales Growth Rate (2016-2021) (K Pcs)
Figure 78. Thailand Antidiabetic Biguanides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Antidiabetic Biguanides Sales Growth Rate (2016-2021) (K Pcs)
Figure 80. Malaysia Antidiabetic Biguanides Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Latin America Antidiabetic Biguanides Sales Growth Rate 2016-2021 (K Pcs)
Figure 82. Latin America Antidiabetic Biguanides Revenue Growth Rate 2016-2021

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Metformin Hydrochloride Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystall......

Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Antidiabetic Sulphonylureas market: According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......

Global Insulin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101

According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......

Global Insulin API Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116

According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period. The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......

Global Glucagon Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101

According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......

Global Acarbose Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period. The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......

Global Insulin Glargine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 77

According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......

Global Liraglutide Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 103

According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......

Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs